OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2022
(4)
2023
(3)
2021
(2)
2026
(1)
2020
(1)
2016
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Management change following NGS diagnosis of inborn errors of immunity: The Australasian experience.
Not available
S-EPMC13629484
|
biostudies-literature
Cite
Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2.
Not available
S-EPMC10037341
|
biostudies-literature
Cite
Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency.
Not available
S-EPMC5187691
|
biostudies-literature
Cite
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.
Not available
S-EPMC9206114
|
biostudies-literature
Cite
Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
Not available
S-EPMC9485705
|
biostudies-literature
Cite
Respiratory viral infections in otherwise healthy humans with inherited IRF7 deficiency.
Not available
S-EPMC9178406
|
biostudies-literature
Cite
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Not available
S-EPMC10074346
|
biostudies-literature
Cite
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
Not available
S-EPMC8532080
|
biostudies-literature
Cite
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Not available
S-EPMC7857407
|
biostudies-literature
Cite
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Not available
S-EPMC9173764
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets